bioMérieux Receives FDA Clearance for Expanded Claims with VIDAS® C. difficile Toxin A&B, Enhancing Testing Solutions for Hospital Infection Control
DURHAM, N.C. (August 6, 2008) — bioMérieux, a world leader in the field of in vitro diagnostics, is bringing a new, rapid solution to the fight against healthcare-associated infections, following clearance from the U.S. Food & Drug Administration (FDA) for expanded claims with VIDAS C. difficile Toxin A&B (CDAB).
Click here
to read the press release
U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis
DURHAM, N.C. (July 24, 2008) — bioMérieux recently conducted two surveys, fielded during conferences of the American Thoracic Society and Society of Hospital Medicine, that show how hospitalists, pulmonary and critical care physicians, and researchers are unanimous in their view that new methods and technologies are needed to quickly diagnose and combat severe bacterial sepsis in U.S. hospitals.
Click here
to read the press release
bioMérieux Unveils an Extended Menu for the VIDAS® Platform at the
American Association for Clinical Chemistry’s 2008 Annual Meeting
Durham, N.C. (July 24, 2008) – bioMérieux, a world leader in the field of in vitro diagnostics, will present an extended line of assays for the VIDAS® platform at the 2008 American Association for Clinical Chemistry (AACC) Annual Meeting July 27-31 in Washington, D.C.
Click here
to read the press release
First-Half 2008 Review
Marcy l'Etoile, France, July 23, 2008– bioMérieux, a global leader in the field of in vitro diagnostics, today released its interim review for the six months ended June 30, 2008.
Click here
to read the press release
bioMérieux Increases its Lead in Microbiology with the Acquisition of the Swedish Diagnostics Specialist AB BIODISK
Marcy l'Etoile, France, June 18, 2008 – bioMérieux, a world leader in the field of in vitro diagnostics has concluded an agreement to acquire the privately held AB BIODISK, a Swedish in vitro diagnostics company with facilities for research and development, manufacturing and marketing located in Stockholm. This is bioMérieux’s fourth acquisition in under two years.
Click here
to read the press release
bioMérieux Awards Geraldine S. Hall the 2008 Sonnenwirth Award for Leadership in Clinical Microbiology
Durham, N.C. (June 2, 2008) – bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Geraldine S. Hall, Ph.D., as the 2008 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology.
Click here
to read the press release
bioMérieux’s Odyssey Tour Brings Education and Training to Healthcare Professionals and Awareness of Healthcare-Associated Infections
Durham, N.C. (May 30, 2008) – bioMérieux, a world leader in the field of in vitro diagnostics, is embarking on a tour across the United States to provide industry professionals with innovative training in advanced diagnostics solutions that aim to improve public health.
Click here
to read the press release
bioMérieux Unveils Full Microbiology Laboratory Automation Solutions
Marcy l’Etoile, France, May 29, 2008 – bioMérieux, a world leader in the field of in vitro diagnostics, will unveil a new suite of “Full Microbiology Laboratory Automation” solutions at the 108th General Meeting of the American Society for Microbiology (ASM), held June 1-5 in Boston.
Click here
to read the press release
FDA Clears bioMérieux’s VIDAS® NT-proBNP
Marcy l’Etoile (France), March 13, 2008 – bioMérieux (Euronext: BIM), a world leader in the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug Administration to market VIDAS® NT-proBNP, a test that helps the diagnosis of heart failure.
Click here
to read the press release
International Diagnostics Company Invests more than $10M in
Facility Upgrades and Advanced Technology
DURHAM, N.C. (November 26, 2007) — bioMérieux, a world leader in the field of in vitro diagnostics, has made major investments in its Durham, N.C. facility as demand for medical testing equipment increases.
Click here
to read the press release
FDA Clears bioMérieux’s VIDAS® B·R·A·H·M·S PCT® Assay
Marcy l’Etoile (France), October 18, 2007 – bioMérieux (Euronext: BIM), a world leader in
the field of in vitro diagnostics, has received 510(k) clearance from the U.S. Food and Drug
Administration to market VIDAS® B·R·A·H·M·S PCT®.
Click here
to read the press release
First–Half 2007 Financial Results Sales up 6.7% like-for-like
Marcy l'Etoile, France - Sept. 17, 2007. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its results for the six months ended June 30, 2007.
Click here
to read the press release
bioMérieux, Inc. Launches New WorkSafe™ Blood Culture Kit
DURHAM, N.C. (July 17, 2007) — bioMérieux, Inc., a leading in vitro diagnostics company, recently announced the launch of its new WorkSafe™ Blood Culture Kit designed to provide a safer and easier process for blood culture collection that can help minimize collection contamination, minimizing the risk of false positives.
Click here
to read the press release
Ergonomic Analysis Shows bioMerieux’s VITEK® 2 and
VITEK® 2 Compact 40-50% More Efficient than
other identification and antibiotic susceptibility testing (ID/AST) systems
DURHAM, N.C. (July 17, 2007) — bioMérieux, Inc.’s VITEK® 2 and VITEK® 2 Compact systems users are at less risk for musculoskeletal disorders than users of other automated bacterial identification and antibiotic susceptibility testing (ID/AST) systems, according to the results of an independent ergonomic analysis.
Click here
to read the press release
bioMérieux, Inc. Kicks Off WorkSafe Initiative to Help Customers Increase Safety from “Collection to Care”
DURHAM, N.C. (May 23, 2007) — In response to rising infection rates and sepsis in U.S. hospitals, bioMérieux, Inc., a leading in vitro diagnostics company, is launching an education campaign to provide labs and infection control personnel with resources and educational materials to support best practices in blood culture collection.
Click here
to read the press release
bioMérieux Recognizes Dr. Vickie S. Baselski with Sonnenwirth Award for Leadership in Clinical Microbiology
DURHAM, N.C. (May 22, 2007) — The 2007 Sonnenwirth Award for Leadership in Clinical Microbiology has been awarded to Vickie S. Baselski, Ph.D. The award will be presented by bioMérieux, Inc. at the American Society for Microbiology (ASM) General Meeting awards dinner in Toronto, Canada on May 22. Dr. Baselski will present a paper titled “Private Matters–Public Affairs.”
Click here
to read the press release
AdvanDx and bioMérieux Partner to Provide Rapid Results for Bloodstream Infections
Woburn, MA, USA & Marcy l’Etoile, France (May 22, 2007) — In order to provide faster identification of bloodstream pathogens, bioMérieux (Euronext: BIM) has agreed with AdvanDx, Inc. to sign an exclusive distribution agreement for the United States for AdvanDx’s PNA FISH™ rapid diagnostic tests.
Click here
to read the press release
bioMérieux, Inc. Empowers Clinical Decisions at Annual American Society for Microbiology General Meeting
DURHAM, N.C. (May 15, 2007) — “Empowering Clinical Decisions”by reducing healthcare-associated infections (HAI) is the underlying theme and bioMérieux’s commitment at the 107th American Society for Microbiology (ASM) General Meeting.
Click here
to read the press releas
bioMérieux Data Management Software, OBSERVA®, Brings Added Efficiencies and Compliance to Blood Bank Industry
DURHAM, N.C. (May 14, 2007) — bioMérieux, Inc., a leading industrial microbiology and diagnostics company, will make its next-generation data management software, OBSERVA® non-interfaced version 3, available to customers within the blood bank industry.
Click here
to read the press release
St. Elizabeth, a CHRISTUS® Health Hospital, is Selected to Pilot
STELLARA™ Clinical Information System
DURHAM, N.C. (May 3, 2007) - bioMérieux, Inc, a leading international diagnostics group, is proud to announce CHRISTUS Health has selected STELLARA™ clinical intervention and patient monitoring software for St. Elizabeth Hospital in Beaumont, Texas.
Click here
to read the press release
bioMérieux’s Third Annual Bus Tour Brings New Products, Education and Training to Customers Nationwide
DURHAM, N.C. & ST. LOUIS (February 20, 2007) — bioMérieux, Inc., a world leader in the field of in vitro diagnostics, will kick off its third annual Innovation in Motion bus tour this month.
Click here
to read the press release
bioMérieux’s Third Annual Bus Tour Brings New Products, Education and Training to Customers Nationwide
DURHAM, N.C. & ST. LOUIS (February 20, 2007) — bioMérieux, Inc., a world leader in the field of in vitro diagnostics, will kick off its third annual Innovation in Motion bus tour this month.
Click here
to read the press release
Cepheid and bioMérieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
Marcy l’Etoile (France) and Sunnyvale, (CA)–January 17, 2007–– Cepheid (NASDAQ: CPHD) and bioMérieux (EuroNext: BIM) announced today that they have entered into a strategic relationship wherein both companies will use the best of their respective technologies and commercial strengths towards the development and commercialization of an innovative line of sepsis test products on the GeneXpert platform.
Click here
to read the press release
bioMérieux licenses technology from NorChip to launch a HPV test for cervical cancer risk detection
Marcy l’Etoile (France) / Klokkarstua (Norway) 17 January 2007 — bioMérieux and NorChip announced today that bioMérieux has entered into a worldwide exclusive license agreement for rights developed by NorChip to an innovative, m-RNA based Human Papillomavirus (HPV) diagnostic, for early detection of cervical carcinogenesis.
Click here
to read the press release
bioMérieux: 2007-2012 Strategy, 2006 Sales
(MARCY-L'ETOILE, FRANCE - January 17, 2007) – bioMérieux, a global leader in the field of
in vitro diagnostics, today announced its strategic plan for 2007-2012.
Click here
to read the press release
View
2006 Press Releases
View
2005 Press Releases
View
2004 Press Releases
View 2003 Press Releases
View 2002 Press Releases
View 2001 Press Releases
|
